$1.500
-0.085 (-5.66%)收盘时
HCAT 资讯
HCAT 事件
Health Catalyst Appoints Simeon Kohl as CEO
Health Catalyst announced that Simeon Kohl has been appointed CEO and president and a member of the company's board of directors, effective September 14. Simeon Kohl most recently served as CEO of Performant Healthcare. Ben Albert concluded that this was the right time to transition the CEO role as Health Catalyst moves into its next phase. He will continue playing a role in the company's future as chief business officer, working closely with Kohl and the leadership team to advance Health Catalyst's strategic priorities.
Health Catalyst Closes Sale of Vitalware for $147 Million
Health Catalyst announced it closed the sale of Vitalware, through which the company conducted its Vitalware business, to Med-Metrix, a technology-enabled revenue cycle management company, on July 31. The transaction included $147M in total cash consideration for Health Catalyst, subject to customary adjustments. The company used those proceeds plus cash on hand to fully repay and retire its obligations under its credit facility, which eliminates approximately $19M in annual interest expense on a GAAP basis, based upon annualizing the first half of 2026.
Sees Q3 Adjusted EBITDA of $0-$500K
Sees Q3 adjusted EBITDA $0-$500K.
Company Reports Q2 Revenue of $70.49M, Exceeding Expectations
Reports Q2 revenue $70.49M, consensus $68.94M. The company recently closed the Vitalware divestiture and fully repaid its credit facility debt, which improves its balance sheet and provides flexibility. "We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance," said CEO Ben Albert.
Sees FY26 Adjusted EBITDA of $18M to $18.5M
Sees FY26 adjusted EBITDA $18M to $18.5M.
相关文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。